Immunosuppressive effects of leflunomide in experimental chronic vascular rejection.
D000818:Animals; D001011:Aorta / Q000637:transplantation*; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015850:Interleukin-6 / Q000096:biosynthesis; D007555:Isoxazoles / Q000494:pharmacology / Q000627:therapeutic use*; D000077339:Leflunomide; D007963:Leukocytes, Mononuclear / Q000187:drug effects* / Q000276:immunology; D007975:Leukotriene B4 / Q000096:biosynthesis; D051381:Rats
D007166:Immunosuppressive Agents; D015850:Interleukin-6; D007555:Isoxazoles; D007975:Leukotriene B4; D000077339:Leflunomide